微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 41.29% | -9.02% | 1.85% | 21/52 | 36.51% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-03-31 | 40.54% | -9.19% | -7.87% | 22/52 | 36.38% | 百诚医药 | 68.75% | 行业排名> |
| 2023-12-31 | 44% | 5.58% | -3.4% | 16/52 | 38.59% | 百诚医药 | 68.19% | 行业排名> |
| 2023-09-30 | 45.55% | 2.46% | 0.37% | 16/52 | 40.28% | 药康生物 | 67.61% | 行业排名> |
| 2023-06-30 | 45.38% | 3.42% | 1.66% | 16/52 | 40.13% | 药康生物 | 69.14% | 行业排名> |
| 2023-03-31 | 44.64% | -1.15% | 7.12% | 19/52 | 39.27% | 药康生物 | 68.49% | 行业排名> |
| 2022-12-31 | 41.67% | -3.92% | -6.25% | 26/52 | 40.44% | 药康生物 | 69.3% | 行业排名> |
| 2022-09-30 | 44.45% | 0.08% | 1.3% | 21/52 | 41.37% | 药康生物 | 71.38% | 行业排名> |
| 2022-06-30 | 43.88% | 0.09% | -2.83% | 23/52 | 40.21% | 药康生物 | 73.27% | 行业排名> |
| 2022-03-31 | 45.16% | 2% | 4.12% | 22/52 | 38.93% | 药康生物 | 75.32% | 行业排名> |
| 2021-12-31 | 43.37% | 0.39% | -1.06% | 26/52 | 42.21% | 药康生物 | 76.7% | 行业排名> |
| 2021-06-30 | 43.84% | 2% | 1.46% | 26/52 | 42.88% | 药康生物 | 74.33% | 行业排名> |
| 2020-12-31 | 43.2% | 1.34% | -2.72% | 26/52 | 38.9% | 南华生物 | 84.53% | 行业排名> |
| 2020-09-30 | 44.41% | 2% | 4.17% | 16/52 | 37.76% | 南华生物 | 83.19% | 行业排名> |
| 2019-12-31 | 42.63% | 1.01% | 1.01% | 26/52 | 43.15% | 南华生物 | 83.9% | 行业排名> |
| 2018-12-31 | 42.21% | 5.18% | 5.18% | 26/52 | 42.47% | 成都先导 | 79.36% | 行业排名> |
| 2017-12-31 | 40.13% | 2% | 2% | 23/52 | 41.42% | 成都先导 | 75.92% | 行业排名> |